Tvax Biomedical

Targeted T cell-based immunotherapies for brain cancer & renal cell carcinoma.

placeLenexa, Kansas, United States calendar_todayFounded 2004 groups6 employees language tvaxbiomedical.com

Social engagement

Social engagement: 443 social following, 1 post in the last 12 months — above the industry median.

Investor mix

3 investors on record; lead investors include Mid America Angels, Kansas Bioscience Authority.

Investor typeCountShare
Venture capital133%
Angel & family office133%
Other / undisclosed133%
Coming soon